Infection and Immunity, May 2000, p. 2393-2401, Vol. 68, No. 5
Department of Biology, Wake Forest
University, Winston-Salem, North Carolina 27109
Received 25 August 1999/Returned for modification 9 November
1999/Accepted 26 January 2000
Immune destruction of larval Taenia crassiceps was
examined by first injecting BALB/cJ mice subcutaneously with larval
buds and 30 to 60 days later challenging the mice with larvae injected into the peritoneal cavity. The larvae injected intraperitoneally (i.p.) secondarily are killed by host cells that completely encase the
larvae in a thick sheath. The peritoneal exudate cells and the
cytokines they produced were characterized by flow cytometry, enzyme-linked immunosorbent assays (ELISAs), and reverse transcription PCR (RT-PCR). No changes in percentage of CD4+ T cells,
CD8+ T cells, B1 cells, or macrophages were detected in the
peritoneal cavities of mice that were killing larvae compared to mice
with a primary 7-day infection i.p. Both RT-PCR and ELISA demonstrated a decrease in cytokines including gamma interferon (IFN- Human cysticercosis is a disease
caused by the larval stage of the cestode parasite Taenia
solium. Humans acquire the larvae by ingestion of eggs released
from the adult tapeworm. Human cysticercosis is common in Mexico and
underdeveloped countries and is increasing in prevalence in North
America (5, 10, 11). Infection of the central nervous system
leads to neurocysticercosis. An excellent model system for the study of
this disease is infection of BALB/c mice with another taeniid parasite,
Taenia crassiceps. The rodent is the natural intermediate
host for this parasite, and the definitive host is a canine. The cysts
multiply in the peritoneal cavity of the mouse by budding asexually in
a seemingly uncontrolled manner, making the BALB/c mice extremely
susceptible to infection. Analysis of the immune response that ensues
during infection has shown that it is a mixed Th1/Th2 phenotype
(15) that is ineffective in controlling parasite growth.
To better determine immune responses that have the capacity to kill
cestode larvae, a model system in which T. crassiceps larvae
are immunologically killed in vivo was developed by a method similar to
one reported earlier (12). In our work, it was found that a
primary subcutaneous (SQ) infection of T. crassiceps larvae induces killing of larvae during a secondary intraperitoneal (i.p.) infection. In the present study, we report the conditions for inducing
larval destruction, the effect of host responses to larvae SQ and i.p.
as observed by scanning electron microscopy (EM), and the cell
populations and cytokine production present i.p. as determined by
enzyme-linked immunosorbent assay (ELISA) and reverse transcription-PCR
(RT-PCR). SQ followed by i.p. infection provides an in vivo model
system in which the complete killing of larval T. crassiceps, and the immune mechanisms required for this killing
can be examined.
Mice and infections.
Six-week-old female BALB/cJ mice were
purchased from The Jackson Laboratory (Bar Harbor, Maine). The ORF
strain of T. crassiceps was used for infections
(6). Parasites were obtained from the peritoneal cavity of
BALB/cJ mice that were infected for 3 to 4 months and were washed three
times with an equal volume of phosphate-buffered saline (PBS; 137 mM
NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.47 mM KH2PO4 [pH 7.2]) under sterile conditions.
Mice were infected by injection of 10 small (<2-mm) larvae in 0.5 ml
of PBS either i.p. or SQ, using a 20-gauge needle. Unless specified
otherwise, mice designated as having SQ infections will be those
infected SQ for 30 to 60 days. Mice infected for 30 to 60 days SQ
followed by i.p. infection are also referred to as challenged mice.
Preparation of larvae and EM.
Larvae were removed from the
peritoneal cavity of mice by peritoneal lavage with 10 ml of PBS, fixed
in 10% formalin for at least 24 h, and then kept at 4°C until
use. The specimens were then covered in 0.1 M Sorenson's physiological
solution containing 2% glutaraldehyde (0.2 M Sorenson's buffer [4
ml] [6.41 g of NaH2PO4, 41.3 g of
Na2HPO4 · 7H2O, pH 7.2, distilled water to 1.0 liter], 8% glutaraldehyde [2 ml], water [2
ml]) and left overnight at 0°C. They were then rinsed with four
changes (30 min each) of 0.1 M Sorenson's buffer, covered with 2%
OsO4 in Sorenson's buffer for 1 h, and taken through
a dehydration series (50% through 100% ethanol). The specimens were
dried in a Pelco CPD-2 critical point dryer (Ted Pella, Inc., Redding,
Calif.), coated with gold in a Pelco SC-4 sputter coater (Ted Pella,
Inc.), and visualized using an Amray (Bedford, Mass.) model 1810 scanning electron microscope, all according to the manufacturer's
instructions. Photographs were taken with positive/negative film
(Polaroid Corp., Cambridge, Mass.).
Peritoneal and spleen cell preparations.
Cells were cultured
in RPMI 1640 with L-glutamine (Mediatech, Herndon, Va.)
supplemented with heat-inactivated fetal bovine serum (Atlanta
Biologicals, Norcross, Ga.) and antibiotics (5 U of penicillin, 5 µg
of streptomycin, and 10 µg of neomycin per ml; Sigma Chemical Co.,
St. Louis, Mo.). This medium is referred to as RPMI-C.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Immune Destruction of Larval Taenia
crassiceps in Mice
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
),
interleukin-4 (IL-4), and IL-10 in mice that were killing the larvae
compared to control mice infected for 30 to 60 days i.p. alone,
although there was little difference compared to mice infected for 7 days i.p. alone. Serum cytokine levels in mice that were killing the larvae showed a decrease in IFN-
and IL-4, an increase in IL-10 when
compared to mice infected for 30 to 60 days i.p. alone, and increases
in all cytokines compared to mice infected for 7 days i.p. alone.
Inhibition of nitric oxide production did not significantly affect the
number or the viability of larvae in the peritoneal cavity of mice that
were killing larvae during secondary infection.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Flow cytometry. PECs were examined for the percentages of CD4+, CD8+, CD5+, B220+, and F4/80+ cells. Phycoerythrin-labeled anti-CD4 (H129.19) and anti-CD8 (53.67) antibodies were used for fluorescent labeling. Nonspecific binding was blocked with FcBlock, and the isotype control was phycoerythrin-labeled rat immunoglobulin G2a. All of these reagents were purchased from PharMingen (San Diego, Calif.) except for the F4/80 antibody, which was purchased from Biosource International (Camarillo, Calif.). One million cells were washed in 1 ml of staining buffer (PBS, 1% bovine serum albumin, 0.1% NaN3 [pH 7.5]) and then stained with 1 µg of the appropriate antibody in 100 µl of staining buffer (30 min, 4°C). Incubation of the unlabeled antibody against the F4/80 macrophage marker was followed by incubation with 1 µg of a fluorescein isothiocyanate-labeled anti-rat antibody in 100 µl of staining buffer (30 min, 4°C). The stained cells were fixed in 500 µl of Ortho Permeafix (Ortho Diagnostics Inc., Raritan, N.J.) and analyzed by flow cytometry (Coulter Epics XL) at the Wake Forest University School of Medicine. Analysis was completed using WinList (Verity Software House, Inc., Topsham, Maine).
Preparation of soluble larval antigen preparation (SLAP).
Larvae were removed from the peritoneal cavity from mice that were
infected for at least 4 months. The larvae were washed three times with
an equal volume of ice-cold PBS, and then all excess PBS was removed.
Packed larvae were then sonicated until no large particles were
apparent. To keep the solution cold, sonication was paused every
30 s and the solution was placed on ice. The preparation was then
homogenized with a smooth pestle tissue grinder to disrupt any
remaining aggregates. Insoluble materials were removed by
centrifugation (20,000 × g, 1 h, 4°C).
Supernatants were filter sterilized, and the protein concentration was
determined by the Bradford method (Bio-Rad, Hercules, Calif.). The
solution was brought to a final protein concentration of 1 µg/ml with
sterile PBS and then stored at
20°C until use.
Spleen cell proliferation and stimulation for cytokine production. Spleen cells were plated in RPMI-C in flat-bottom, polystyrene 96-well plates (Corning Glass Works, Corning, N.Y.) at 5 × 105 cells/well in triplicate and were stimulated with indicated concentrations of concanavalin A (ConA; Sigma, St. Louis, Mo.) or SLAP in a final volume of 250 µl/well. After 60 h of incubation, 1 µCi of [3H]thymidine (ICN Pharmaceuticals, Irvine, Calif.) diluted in 10 µl of RPMI-C was added to each well. Thymidine incorporation was measured by liquid scintillation spectroscopy (LS-1801; Beckman Instruments Inc., Fullerton, Calif.).
PECs were cultured at 2 × 105 cells/well in medium alone, with ConA (5 µg/ml) or SLAP (10 µg/ml), in a final volume of 250 µl. Approximately 10 wells of each treatment were run. After 24 h, 150 µl of supernatant was removed and frozen at
20°C
until needed.
Cytokine ELISAs.
Capture and detection antibodies were
purchased from PharMingen, and ELISAs were run according to the
manufacturer's protocol. The concentrations of gamma interferon
(IFN-
), interleukin-4 (IL-4), and IL-10 in each sample were
determined in triplicate, and the mean of each sample was calculated.
Sensitivities of the ELISA for IFN-
, IL-10, and IL-4 were 10, 2, and
2 pg/ml, respectively.
RT-PCR.
RNA was extracted from 107 PECs as
previously described (2). RNA was analyzed
spectrophotometrically (Beckman DU-64) by measuring concentration at
260 nm and testing for purity using the
A260/A280 ratio. All RNA
samples had an A260/A280
ratio of between 1.5 and 2.0. Two micrograms of RNA was reverse
transcribed in 40-µl reactions using Moloney murine leukemia virus
reverse transcriptase (Amersham Life Science, Inc., Cleveland, Ohio) at 200 U/µl and oligo(dT)12-18 (Pharmacia, Piscataway,
N.J.) at 1 µg/ml. cDNAs were precipitated and resuspended in
deionized water, and then cytokine-specific cDNAs were amplified by PCR using the following conditions and primers: 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 0.11 mM each deoxynucleoside triphosphate, 2.3 pmol of each
cytokine-specific primer (1) or
-actin-specific primer
(3' primer, 5'CTCTTTGATGTCACGCACGATTTTC3'; 5' primer,
5'GACGAGGCGCAGAGCAAGAGAGG3') per µl, 1.15 mM
MgCl2, and 1.3 U of AmpliTaq DNA polymerase (Perkin-Elmer, Branchburg, N.J.) in a 50-µl reaction in Thermolyne oil-free tubes (Barnstead Thermolyne Corp., Dubuque, Iowa). Cycle conditions were as
follows: premelting at 95°C for 2 min, annealing at 52°C for 1 min,
elongation at 72°C for 1 min, and denaturation at 95°C for 50 s (35 cycles [25 cycles for
-actin]), final anneal at 52°C for 2 min, and final elongation at 72°C for 2 min. PCR products were run on
a 1.5% agarose gel in Tris acetate buffer containing ethidium bromide.
Gels were imaged and analyzed on an AlphaImager 2000 (Alpha Innotech
Corporation, San Leandro, Calif.) using spot densitometry. Ratios of
the cytokine PCR product to the corresponding
-actin PCR product
were compared.
Detection of nitric oxide. Nitric oxide production by PECs was detected using the Greiss reaction as previously described (7). Briefly, 50 µl of 1% sulfanilimide solution and 50 µl of 1% naphthylethylenediamine dihydrochloride were added to 50-µl samples in a 96-well plate. Absorbance was measured at 550 nm.
Nitric oxide inhibition. BALB/cJ mice were injected SQ with 10 T. crassiceps larvae and then 30 to 60 days later injected i.p. with 10 larvae. Immediately thereafter, one half of the mice were injected i.p. with aminoguanidine (50 µg/kg of body weight in 500 µl of sterile PBS), and this injection was continued twice daily using the same concentration of aminoguanidine. Control mice received injections of PBS (500 µl). After 7 days, the mice were killed by cervical dislocation, larvae were counted, and serum and PECs were obtained as described.
Statistical analyses. Data were analyzed for statistical significance using Student's t test. Unless otherwise stated, data are presented as means ± standard deviation and were considered significantly different when P was <0.05.
| |
RESULTS |
|---|
|
|
|---|
Primary SQ infection prevents secondary i.p. infection. To determine if a primary infection of larvae would prevent the establishment of a secondary infection, mice were infected SQ for 100 days and then i.p. for 30 days. Mice that received an initial SQ injection of larvae destroyed all larvae (n = 3) in the peritoneal cavity, whereas mice receiving larvae only i.p. had progressing infections (27.0 ± 8.5; n = 3).
To examine the development of antilarval immunity, groups of mice were injected SQ with 10 buds and then 2, 4, 6, or 8 weeks later injected i.p. with 10 buds. Mice were killed 1 week after the i.p. infection, and the larvae were counted; there were no significant differences in numbers of larvae or viable larvae recovered from the peritoneal cavity between the groups of mice (data not shown). Regardless of duration of SQ infection, the larvae injected i.p. were killed. Based on these observations, in subsequent experiments mice were infected SQ for 30 to 60 days followed by i.p. infection. When this approach was followed, mice infected SQ for 30 to 60 days and then infected i.p. for 7 days showed a high level of larval destruction (Fig. 1A). It is clear from these data that the immune responses able to kill the larvae were developing effectiveness by day 7. Because it is important to examine killing responses as they are occurring instead of at the culmination of rejection, it was necessary to demonstrate that after the 7-day time point, the mice continued to kill the larvae present in the peritoneal cavity. Repeating the experiment but allowing the i.p. infection to progress for 14 days, we recovered a maximum of one larva from the peritoneal cavity of any mouse, confirming that at day 7 larvae in the peritoneal cavity were in the process of immunological destruction, and this continued for at least the next 7 days (Fig. 1B).
|
Condition of larvae recovered from the peritoneal cavity.
Larvae removed from both the SQ and i.p. locations were prepared for
scanning EM. Figures 2A and B show
scanning electron micrographs of larvae removed from mice infected i.p.
alone for 7 days. Figure 2A is representative of larvae removed from
the peritoneal cavity. Due to the dehydration and critical point drying process, some damage to the tegument of the larvae occurred. Otherwise, the larvae were intact and undamaged when removed from the peritoneal cavity. Figure 2B shows the surface of a larva under greater
magnification; the microtrichs are plainly visible.
|
|
Composition of PECs. PECs from mice infected i.p. for 7 days and mice infected SQ followed by infection i.p. were stained for the presence of CD4+ T cells, CD8+ T cells, B220+ cells, CD5+ cells, and macrophages. Flow cytometry did not reveal any significant differences in the composition of PECs between the two groups of mice (data not shown).
Proliferation of spleen cells.
To estimate the immune response
of splenocytes to ConA and to larval antigens in culture, splenocytes
(5 × 105/well) were stimulated with different
concentrations of ConA or SLAP. When stimulated with ConA, splenocytes
from SQ-infected mice proliferated significantly less than all other
splenocytes from all other groups of mice (Fig.
4A). Proliferation of splenocytes from
mice infected for 7 days i.p., mice infected for 30 to 60 days i.p.,
and mice infected SQ followed by infection i.p. did not show
significant differences at a ConA concentration of 5 µg/ml or less.
At 10 µg of ConA per ml, splenocytes from mice infected for 7 days
i.p. and mice infected SQ followed by i.p. infection showed
significantly less proliferation than both normal mice and mice
infected for 30 to 60 days i.p. along. Interestingly, splenocytes from
mice infected SQ alone proliferated significantly less in response to
all concentrations of ConA than spleen cells from other groups of mice,
infected or uninfected (Fig. 4A).
|
Cytokine production in PECs.
PECs were cultured for 24 h
in RPMI-C alone, with ConA (5.0 µg/ml), or with SLAP (10 µg/ml),
and cytokine production was measured by ELISA. Unstimulated or
SLAP-stimulated PECs from mice infected SQ followed by i.p. infection
produced significantly less IFN-
compared to mice infected i.p.
alone for 30 to 60 days (Fig. 5A and C).
IFN-
production by PECs from mice infected SQ followed by i.p.
infection was not significantly different from the production by PECs
of mice infected i.p. alone for 7 days in ConA-stimulated cultures but
was significantly lower in unstimulated and SLAP-stimulated cultures
(Fig. 5).
|
|
|
RT-PCR of cytokine-specific mRNA from PECs.
RNA was harvested
from PECs ex vivo, and levels of mRNA for IFN-
, IL-4, IL-10, and
IL-2 were determined as ratios against
-actin. RT-PCR confirmed
results from ELISAs that IFN-
, IL-4, and IL-10 production were all
downregulated in PECs from mice infected SQ followed by i.p. infection
compared to mice infected i.p. alone for 30 to 60 days and mice
infected i.p. alone for 7 days (data not shown). Production of IL-2 was
not measured by ELISA, but RT-PCR indicated that IL-2 was upregulated
in mice infected SQ followed by i.p. infection compared to mice
infected i.p. alone for 30 to 60 days and in mice infected i.p. alone
for 7 days (data not shown).
Serum cytokine levels.
IFN-
levels were significantly
higher in mice infected SQ followed by i.p. infection than in
uninfected controls, mice infected i.p. alone for 7 days, and mice
infected only SQ. However, compared to mice infected i.p. alone for 30 to 60 days, IFN-
in mice infected SQ followed by i.p. infection was
significantly lower (Fig. 8A). Levels of
IL-4 in the serum of mice infected SQ followed by i.p. infection was
significantly higher than in uninfected mice, mice infected i.p. alone
for 7 days, and mice infected only SQ but were significantly lower than
in mice infected i.p. alone for 30 to 60 days (Fig. 8B). Serum levels
of IL-10 in mice infected SQ followed by i.p. infection were
significantly higher than in all other groups of mice tested (Fig. 8C).
|
Production of nitric oxide by PECs.
In challenged mice, nitric
oxide production by PECs in response to ConA stimulation was measured
on day 7 of i.p. infection alone or on day 7 in challenge infections.
The NO level was higher in challenged mice than in mice infected i.p.
alone for 7 days (Fig. 9B). However, when
cells were unstimulated or stimulated with SLAP, NO production by PECs
from challenged mice was not different from that in mice infected i.p.
alone for 7 days (Fig. 9A and C). NO production by PECs from mice
infected for 30 to 60 days i.p. only was significantly higher than that
of mice infected for 7 days i.p. only and of challenged mice in
unstimulated, ConA-stimulated, and SLAP-stimulated conditions (Fig. 9).
|
Effect of nitric oxide inhibitors on the killing of larvae. Mice infected SQ followed by i.p. infection were treated with aminoguanidine, a nitric oxide inhibitor, to determine if nitric oxide played a role in the killing of larvae. Mice received twice-daily i.p. injections of 50 µg of aminoguanidine/kg of body weight in PBS or twice-daily injections of PBS alone beginning the day larvae were injected i.p. Treatment with the nitric oxide inhibitor did not significantly affect the total number of larvae recovered (treated, 9 ± 6; controls, 3.7 ± 0.58) or the numbers of viable larvae (treated, 2.3 ± 3.2; controls, 0.66 ± 1.2) that were recovered from the peritoneal cavity after 7 days of i.p. infection.
Primary i.p. infection prevents secondary SQ infection. It was necessary to determine if the effect of primary infection and secondary challenge of larvae was similar if the sites of first injection were reversed. Groups of mice were injected i.p. for 30 days followed by SQ injection and with SQ only for 7 days. In these experiments, the secondary SQ larvae were killed (0.5 ± 1.0; n = 6), and the primary i.p. larvae (123 ± 16; n = 3) were apparently unharmed (for SQ-only controls, the values were 6 ± 1.0 [n = 3]). This demonstrated that the ability to immunologically reject larvae apparently is not limited to the i.p. site of infection and that killing occurs to those larvae in the challenge infection.
It has been reported previously that mice chronically infected with larval T. crassiceps are severely immunosuppressed (16; S. A. Toenjes, R. J. Spolski, M. A. Alexander-Miller, K. A. Mooney, and R. E. Kuhn, submitted for publication). To determine if this immunosuppression yielded mice ineffective at killing a secondary challenge of larvae, mice chronically infected i.p. (4 months) were injected SQ with larvae and killed 7 days later. The number of secondary SQ larvae that were recovered from challenged mice was not statistically different from that for mice infected SQ alone for 7 days, suggesting that the immunosuppression in chronically infected mice inhibits immune rejection of larvae in the challenge infection (7-day SQ-only controls, 6.0 ± 1.0 [n = 3]; chronic i.p. infection followed by SQ infection, 6.7 ± 1.0 [n = 3]).| |
DISCUSSION |
|---|
|
|
|---|
Previous studies have shown that a primary SQ infection of T. crassiceps larvae can induce killing of a challenge infection of larvae (12-14). In none of these studies, however, was the killing response as immediate or effective as observed in our experiments (12). The differences in the results between our studies and the experiments of Siebert and Good (12) may be due to the fact that they used only 3 larvae per injection in both SQ and i.p. infections, whereas we used 10 larvae per injection. The larger dose of larvae SQ may have induced a stronger, more rapid, and more effective killing response in our experiments. In the experiments by Siebert and Good (12), however, there were also fewer larvae (3 versus 10) to be killed, yet they did not observe complete rejection of larvae.
The killing response observed in the present study was coincident with adherence of a sheath of host cells to the tegument of the larvae. Characteristics of the sheath of cells and fibrous material that surrounded larvae appeared different between viable and nonviable larvae. Viable larvae had a very dense layer of cells around them, whereas dead larvae had fewer cells and a dense, fibrous matrix surrounding them (Fig. 3). This difference may reveal different phases of the host cell attack against the larvae. Continued adherence of host cells to the surface of larvae may cease once larvae have died. Because there are fewer cells on the larval surface, the dense matrix that has been deposited on the larval surface may be more visible by scanning EM. Also, the density of the matrix may increase as the destructive activities progress; i.e., a denser matrix would indicate a more advanced stage of the killing response and would be more apparent on the tegument. The source and characterization of this matrix material are under investigation.
Flow cytometry of PECs from mice infected i.p. alone for 7 days and from challenged mice did not indicate any significant changes in the percentages of CD4+ T cells, CD8+ T cells, B220+ cells, CD5+ cells, B220 CD5+ cells, or macrophages. This was unexpected, as it might be predicted that there would be an increase or a decrease in some cell populations during the killing response. It is possible that the infiltrating cell populations differed but that the crucial effector populations were bound to the larvae. Flow cytometry was not performed on the cell layers adhered to the larvae, but in the future this may reveal some interesting information.
Despite the intense killing response in the peritoneal cavity of challenged mice, the proliferation of spleen cells from these mice in response to ConA was not significantly higher than that of spleen cells from mice infected i.p. alone for 7 days, mice infected i.p. alone for 30 to 60 days, or uninfected mice (Fig. 4A). It is also notable that when stimulated with SLAP, the mice infected SQ alone and mice infected i.p. alone for 30 to 60 days showed greater proliferation than challenged mice, which was not anticipated (Fig. 4B). Also, the proliferation of the spleen cells from these mice in response to ConA and to SLAP was comparatively low. It may be that the proliferative capacity of the spleen cells is unrelated to the killing response that is induced by SQ infection, making the splenocyte blast assay a less useful measure of immunity.
IFN-
was downregulated in challenged mice compared to mice infected
i.p. alone for 30 to 60 days in unstimulated, ConA-stimulated, and
SLAP-stimulated cultures (Fig. 5). IFN-
was also downregulated compared to mice infected i.p. alone for 7 days in unstimulated and
SLAP-stimulated cultures. Considering the intense inflammatory response
that was occurring in the peritoneal cavity, significant production of
IFN-
would be anticipated. Serum levels of IFN-
were high in mice
infected SQ followed by i.p. infection, indicating that there was
significant systemic production of IFN-
(Fig. 8A); however, ELISAs
and RT-PCR showed that the PECs were not producing this cytokine. The
highest levels of IFN-
in serum were in the mice infected i.p. alone
for 30 to 60 days. IFN-
production, then, is highest in mice with
progressing larval infection and is lower in the serum and in
production by PECs of mice that are killing the larvae. This argues
against the possibility that IFN-
plays the prominent role by
inducing inflammation and Th1-associated responses in PECs during the
killing of larvae. Other work on larval T. crassiceps
infection has shown that IFN-
levels in the serum consistently rise
over the course of infection, indicating again that the presence of
this cytokine is associated with heavy infection (15). It is
also of note that the production of IFN-
in response to SLAP by PECs
from mice infected i.p. only for 7 days, and for 30 to 60 days i.p.
alone, produce high levels of IFN-
, but that PECs from challenged
mice do not.
When unstimulated, stimulated with ConA, or stimulated with SLAP, PECs from mice infected for 7 days i.p. alone produced levels of IL-10 that were significantly higher than levels produced by PECs from mice infected for 30 to 60 days i.p. alone and from challenged mice. This early production of high levels of IL-10 during larval T. crassiceps infection in BALB/c mice has been demonstrated previously (15). IL-10 is known as a downregulatory cytokine (3, 4), and the early production of high levels of IL-10 may inhibit the immune response from destroying the larvae (15). These observations are consistent with the finding that in challenged mice that are killing the larvae, production of IL-10 by PECs is very low (Fig. 7A). This provides more evidence that production of IL-10 by PECs early in infection is conducive to heavy parasitism but does not coincide with serum levels of IL-10, because in challenged mice levels of IL-10 in serum were approximately six times higher than in mice infected 7 days i.p. alone.
Inhibition of NO production did not significantly affect the number or viability of parasites recovered from the peritoneal cavity of challenged mice. NO has been implicated as playing a role in immunity in a number of parasitic diseases and as being able to decrease the burden of both intracellular and extracellular parasites (9, 17). NO production by PECs from challenged mice was always lower than that of mice infected for 30 to 60 days i.p. alone. Compared to mice infected for 7 days i.p. alone, production of NO by PECs stimulated with ConA was higher in challenged mice (Fig. 9B). Despite inhibition of NO production in vivo in challenged mice, there was no significant change in the number of parasites recovered from the peritoneal cavity.
It is of interest to determine why larvae in a secondary infection are killed while the primary infection of larvae remains unaffected. By reversing the injections of the larvae to a primary i.p. infection followed by a SQ challenge, the SQ larvae were killed and the i.p. larvae were apparently unharmed. This suggests that the parasites that are killed are restricted to the secondary infection, and that the parasites in the primary infection are unharmed.
| |
ACKNOWLEDGMENT |
|---|
This research was supported by grant AI 35730 from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: P.O. Box 7325, Department of Biology, Wake Forest University, Winston-Salem, NC 27109. Phone: (336) 758-5022. Fax: (336) 758-6008. E-mail: kuhnray{at}wfu.edu.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Benavides, G. R., B. Hubby, W. M. Grosse, R. A. McGraw, and R. L. Tarelton. 1995. Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primer sets. J. Immunol. Methods 181:145-156[CrossRef][Medline]. |
| 2. | Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinum thiocyanate phenol chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 3. | Ding, L., P. S. Linsley, L. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234[Abstract]. |
| 4. | Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451[Abstract]. |
| 5. | Flisser, A. 1988. Neurocysticercosis in Mexico. Parasitol. Today 4:131-137. |
| 6. | Freeman, R. 1962. Studies on the biology of Taenia crassiceps (Zender 1980) Rudolphi, 1210 (Cestoda). Can. J. Zool. 40:969-990. |
| 7. | Green, S. J., J. Aniagolu, and J. J. Raney. 1998. Oxidative metabolism of murine macrophages, p. 14.5.1-14.5.11. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology, vol. 3. John Wiley & Sons, New York, N.Y. |
| 8. | Hanks, J. H., and J. H. Wallace. 1958. Determination of cell viability. Proc. Soc. Exp. Biol. Med. 98:188. |
| 9. | Liew, F. Y., S. Millott, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797[Abstract]. |
| 10. | Mahajan, R. C. 1982. Geographical distribution of human cysticercosis, p. 39-46. In A. Flisser, K. Willms, J. P. Laclette, C. Larralde, C. Ridaura, and F. Beltrán (ed.), Cysticercosis: present state of knowledge and perspectives. Academic Press, New York, N.Y. |
| 11. | Schantz, P. M., A. C. Moore, J. L. Munoz, B. J. Hartman, J. A. Schaefer, A. M. Aron, D. Persaud, E. Sarti, M. Wilson, and A. Flisser. 1992. Neurocysticercosis in an orthodox Jewish community in New York City. N. Engl. J. Med. 327:692-695[Abstract]. |
| 12. | Siebert, A. E., Jr., and A. H. Good. 1980. Taenia crassiceps: immunity to metacestodes in BALB/c and BDF1 mice. Exp. Parasitol. 50:437-446[Medline]. |
| 13. | Siebert, A. E., Jr., A. H. Good, and J. E. Simmons. 1979. Kinetics of primary and secondary infection with Taenia crassiceps metacestodes (Zeder, 1800) Rudolphi, 1810, (Cestoda: Cyclophyllidea). Int. J. Parasitol. 8:39-43. |
| 14. | Siebert, A. E., Jr., A. H. Good, and J. E. Simmons. 1979. Ultrastructural aspects of the host cellular immune response to Taenia crassiceps metacestodes. Int. J. Parasitol. 9:323-331[Medline]. |
| 15. | Toenjes, S. A., R. J. Spolski, K. A. Mooney, and R. E. Kuhn. The systemic immune response of BALB/c mice infected with larval Taenia crassiceps is a mixed Th1/Th2-type response. Parasitology 118:623-633. |
| 16. | Villa, O. F., and R. E. Kuhn. 1996. Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1-associated phenomena. Parasitology 112:561-570. |
| 17. | Wynn, T. A., I. P. Oswald, I. A. Eltoum, P. Caspar, C. J. Lowenstein, F. A. Lewis, S. L. James, and A. Sher. 1994. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:5200-5209[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»